Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...

T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

Investigators at the Jacobs School have uncovered how heat causes a critical receptor protein within cells to unfold and relay pain, which could open up new therapeutic targets for treating pain.

In the wake of novel bispecific and chimeric antigen receptor T-cell therapies for various cancers, geography still plays a big role in patients' abilities to receive such treatments.

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for treating unresectable or metastatic NSCLC.

Professor Yeo says if the neuronal sensors and brain pathways involved in appetite regulation are better understood, it may ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Anixa Biosciences (NASDAQ:ANIX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga ...

Artificial sweeteners are everywhere, marketed as a healthier alternative to sugar, but new research suggests they may not be ...